translocations or amplifications along with the genomic alterations already present in the initial CLL, but absence the prevalent mutations observed in Main DLBCL indicating they may well correspond to a unique Organic group.Deep, targeted next-generation sequencing has exposed that subclonal mutations (i.e., Individuals current in only a fraction